Literature DB >> 8175137

Ultrastructural location of human hepatocyte growth factor in human liver.

H Sakaguchi1, S Seki, H Tsubouchi, Y Daikuhara, Y Niitani, K Kobayashi.   

Abstract

Human hepatocyte growth factor has been purified from the plasma of patients with fulminant liver failure, but where this factor is produced in organs or cells of subjects with liver diseases is unknown. Therefore, we used a monoclonal antibody to human hepatocyte growth factor to stain cells in three normal and 29 diseased liver tissues by immunohistochemical techniques. By light microscopy, the immunostained cells seemed to be polymorphonuclear leukocytes because of their segmented nuclei. Some biliary epithelial cells also were stained. Electron microscopy confirmed that the immunostained cells with segmented nuclei were polymorphonuclear leukocytes and that the stained grains were on the membranes of rough endoplasmic reticulum, around specific or azurophilic granules and in the cell sap. Stained grains in the biliary epithelial cells were found sporadically on the inside and outside of the membranes of rough endoplasmic reticulum near the nuclei. Human hepatocyte growth factor is now known to be the same protein as scatter factor and tumor cytotoxic factor, both of which are produced by human fibroblasts in culture, but our results suggest that polymorphonuclear leukocytes in diseased livers are one cellular source of circulating human hepatocyte growth factor. The immunostaining properties of biliary epithelial cells in diseased livers also suggest that the cells produce and secrete human hepatocyte growth factor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175137

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis.

Authors:  Y Yasunaga; Y Shinomura; S Kanayama; Y Higashimoto; M Yabu; Y Miyazaki; S Kondo; Y Murayama; H Nishibayashi; S Kitamura; Y Matsuzawa
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

2.  Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.

Authors:  T Tomiya; I Ogata; K Fujiwara
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

3.  Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure.

Authors:  P Harrison; C Gove; A Bomford
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

4.  Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway.

Authors:  Jiang-Rui Guo; Wei Li; Yong Wu; Lin-Qing Wu; Xin Li; Ya-Fei Guo; Xiao-Hui Zheng; Xiao-Lan Lian; Hui-Fang Huang; Yuan-Zhong Chen
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

5.  Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.

Authors:  E Santoni-Rugiu; K H Preisegger; A Kiss; T Audolfsson; G Shiota; E V Schmidt; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

6.  Hemoglobin as a possible biochemical index of hypertension-induced vascular damage.

Authors:  Yuji Shimizu; Koichiro Kadota; Mio Nakazato; Yuko Noguchi; Jun Koyamatsu; Hirotomo Yamanashi; Mako Nagayoshi; Shuichi Nagata; Kazuhiko Arima; Takahiro Maeda
Journal:  J Physiol Anthropol       Date:  2016-01-28       Impact factor: 2.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.